✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Everest Medicines Ltd

Common Name
Everest Medicines
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
812
Ticker
1952
Exchange
Hong Kong Exchanges and Clearing Limited
Description
Everest Medicines Ltd. is a biopharmaceutical company primarily focused on the development and commercialization of transformative pharmaceutical products. Its primary aim is to address critical unmet...

Everest Medicines's Climate Target Data Preview

As of 2025, Everest Medicines has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Everest Medicines's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target*
Scope 1 - Total, Scope 2 - Total, Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Employee
-5%a
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/climate-targets?ticker=1952"

Verified Sources Behind Everest Medicines’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Everest Medicines's ESG Report 2025

Insights into Everest Medicines's Greenhouse Gas Emissions Pathways

As of 2025, Everest Medicines has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories.a

Does Everest Medicines have a target to reduce its total carbon footprint?

As of 2025, Everest Medicines has set a target to reduce its total carbon footprint, specifically those from Scope 1, Scope 2 and Scope 3 sources.a

Everest Medicines's most ambitious carbon footprint target is to reduce its scope 1, 2 and 3 emissions from a baseline of 7.41 Metric Tonnes of CO2 equivalent (mtCO2e) per Employee in 2024, by 5% by 2030.a

Everest Medicines has already surpassed its total carbon footprint reduction target, with 2025 levels falling below the 2030 value, achieving its climate goal ahead of schedule.a

Everest Medicines's Carbon Footprint (Scope 1+2+3) Emissions Pathway

20242025203002468Current (-11%)
Want Full Access to Everest Medicines's Climate Targets Dataset?
Start 30-Day Free Trial